# The Oxford Marfan Trial

> **NCT01949233** · PHASE2 · UNKNOWN · sponsor: **University of Oxford** · enrollment: 56 (estimated)

## Conditions studied

- Marfan Syndrome

## Interventions

- **DRUG:** Irbesartan 150-300mg capsules daily for 6 months
- **DRUG:** Doxycycline 100-200mg capsules daily for 6 months
- **DRUG:** Doxycycline placebo capsules daily for 6 months
- **DRUG:** Irbesartan placebo capsules daily for 6 months

## Key facts

- **NCT ID:** NCT01949233
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2017-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2015-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01949233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01949233, "The Oxford Marfan Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01949233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*